Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » Zymo Research Granted FDA Emergency Use Authorization for Coronavirus Molecular Kit

Zymo Research Granted FDA Emergency Use Authorization for Coronavirus Molecular Kit

May 08, 2020
|
staff reporter

NEW YORK ─ The US Food and Drug Administration on Thursday granted Emergency Use Authorization to life science reagent company Zymo Research for its Quick SARS-CoV-2 rRT-PCR Kit for the detection of SARS-CoV-2 coronavirus.

The molecular kit, developed by the Irvine, California-based firm, has been authorized as a laboratory test for the detection of nucleic acid from SARS-CoV-2 in upper and lower respiratory specimens from patients suspected of COVID-19, the agency said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Changes to the Lancet's Process

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

Emails Show Pressure on CDC

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

Into One System

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

PLOS Papers on Dilated Cardiomyopathy, Lung Cancer Epigenetics, Pediatric Staphylococcus aureus Infections

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

  2. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  3. FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

  4. DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

  5. Eurobio Gets CE Mark for Multiplexed SARS-CoV-2, Influenza A/B, RSV Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.